Blood sugar fluctuations: Managing blood sugar levels is critical for individuals with diabetes, and Mounjaro helps in this regard
N Engl J Med 377:839848 Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Researchers studied 47,199 patients with cardiovascular disease who received Novo Nordisk's GLP-1 drug semaglutide, sold as Ozempic for diabetes and Wegovy for obesity, for up to two years
Jerry: She got it and she suggested I look into it or at least talk to the weight loss doctor and I did
If retatrutide can produce maximum weight loss at 9-12mg and then maintain it at 4mg, the long-term side effect burden and cost could drop substantially
More studies are needed, but the potential is there